28 February 2020 2 6K Report

Background information:

Between approximately 2005 and 2014, a company called Invitrogen (later Life Technologies, currently ThermoFisher) marketed special peptides for protein kinase assays. Kinase-catalyzed phosphorylation of these substrates is accompanied an increase in fluorescence intensity, because of a special Mg+2-chelating aminoacid ("Sox" or "cSx") built into each particular peptide sequence [1]. Some researchers who used this assay did publish the sequence of the given peptide. See for example Ref. [2] below, where the sequence of a peptide marketed by Invitrogen under the catalog name "Y12" was Ac-Glu-Glu-Glu-Glu-Tyr-Ile(cSx)-Ile-Val-NH2. Invitrogen, under a license from MIT, sold several dozen of these kinase substrates. There are quite a few scattered papers in the biochemical literature, but unfortunately not all of them list the detailed sequence of the peptide substrates.

Now the question:

Is there anyone who would have in their possession some type of a document (maybe an old Invitrogen product manual, technical note, or any other material) that would list the peptide sequence of each particular kinase substrate marketed by Invitrogen under the Omnia® trade mark? If so, could you please either post that document here, or just contact me directly via email? Thanks very much in advance for your time.

REFERENCES

[1] Shults, M. D., and Imperiali, B., "Versatile fluorescence probes of protein kinase activity", J. Am. Chem. Soc. 125 (2003) 14248-14249.

[2] Schwartz, P. A., Kuzmic, P., Solowiej, J., Bergqvist, S., Bolanos, B., Almaden, C., Nagata, A., Ryan, K., Feng, J., Dalvie, D., Kath, J., Xu, M., Wani, R., and Murray, B. W., "Covalent EGFR inhibitor analysis reveals importance of reversible interactions to potency and mechanisms of drug resistance", Proc. Natl. Acad. Sci. U.S.A. 111 (2014) 173–178.

More Petr Kuzmic's questions See All
Similar questions and discussions